Digestive and Liver Disease - Volume 48 - Supplement 2 - February 2016
|
Editors Board |
2 |
|
Copyright Notice |
2 |
|
Contents |
4 |
|
Publication Information |
5 |
|
22nd National Congress of Digestive Diseases, Italian Federation of Societies of Digestive Diseases – FISMAD Naples, 24–27 February 2016 |
6 |
|
PC.01 Plenary Session |
6 |
|
PC.01.1 MANAGEMENT OF BILIARY ANASTOMOTIC STRICTURE AFTER LIVER TRANSPLANTATION (BASALT STUDY): RESULTS OF A NATIONAL SURVEY IN ITALY |
6 |
|
PC.01.2 PREDICTIVE VALUE OF THE “DICA” ENDOSCOPIC CLASSIFICATION ON THE OUTCOME OF THE DIVERTICULAR DISEASE OF THE COLON: AN INTERNATIONAL STUDY |
7 |
|
PC.01.3 KNOCKDOWN OF SMAD7 WITH MONGERSEN ATTENUATES COLITIS AND COLITIS-DRIVEN FIBROSIS IN MICE |
7 |
|
PC.01.4 PERIBILIARY GLANDS AS A NICHE OF EXTRA-PANCREATIC INSULIN-PRODUCING AND GLUCOSE-SENSITIVE CELLS |
8 |
|
PC.01.5 A NEW SUB-CLASSIFICATION OF ESOPHAGO-GASTRIC JUNCTION MORPHOLOGY TYPE I HELPS TO BETTER RECOGNIZE PATIENTS WITH A POSITIVE IMPEDANCE-PH MONITORING |
8 |
|
PC.01.6 RISK FACTORS FOR THE OCCURRENCE OF SPORADIC PANCREATIC NEUROENDOCRINE TUMOURS: A MULTICENTER EUROPEAN STUDY (EPINET) |
9 |
|
PC.01.7 EUROPEAN COLONOSCOPY QUALITY INVESTIGATION GROUP: IMPROVING STANDARDS IN COLONOSCOPY THROUGH A PRACTICE LEVEL AUDIT TOOL |
9 |
|
PC.01.8 SERUM DETERMINATION OF SQUAMOUS CELLULAR CARCINOMA ANTIGEN AS A BIOMARKER OF BARRETT’S ESOPHAGUS AND ESOPHAGEAL CANCER: A PHASE III STUDY |
9 |
|
Oral Communications |
11 |
|
OC.01 Endoscopy 1 |
11 |
|
OC.01.1 THE VALUE OF CONTRAST ENHANCED ENDOSCOPIC ULTRASOUND IN THE FINE NEEDLE ASPIRATION |
11 |
|
OC.01.2 PRELIMINARY RESULTS OF MACROSCOPIC VISUAL ADEQUACY EVALUATION OF EUS-FNA SAMPLES |
11 |
|
OC.01.3 ENDOSCOPIC ULTRASOUND-GUIDED FINE NEEDLE ASPIRATION, CELL-BLOCK APPROACH: EXPERIENCE IN A SINGLE CENTER |
11 |
|
OC.01.4 EUS PREDICTIVE FACTORS OF RECURRENCE IN PATIENTS WITH LOCAL ADVANCED RECTAL CANCER |
12 |
|
OC.01.5 ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD) OF LARGE SUPERFICIAL COLORECTAL NEOPLASMS AT THE DENTATE LINE OR ILEOCECAL VALVE |
12 |
|
OC.01.6 UNDERWATER ENDOSCOPIC MUCOSAL RESECTION: THE THIRD WAY FOR EN BLOC RESECTION OF COLONIC LESIONS? |
13 |
|
OC.01.7 ENDOSCOPIC MANAGEMENT OF PATIENTS WITH POST-SURGICAL LEAKS INVOLVING THE GASTROINTESTINAL TRACT. A LARGE CASE SERIES |
13 |
|
OC.01.8 SPLIT VS SAME-DAY REGIMES FOR BOWEL PREPARATION BEFORE COLONOSCOPY: A META-ANALYSIS OF PUBLISHED STUDIES |
13 |
|
OC.01.9 OLGA–BASED STAGING AND DYSPLASIA RELEVANCE IN 50–70 YEARS OLD PATIENTS IN A PRIMARY OPEN ACCESS ENDOSCOPY: PRELIMINARY RESULTS |
14 |
|
OC.02 IBD 1 |
14 |
|
OC.02.1 HIGH EXPRESSION OF DUBA, A REGULATOR OF T CELL ACTIVATION, IN INFLAMMATORY BOWEL DISEASE |
14 |
|
OC.02.2 HUMAN NEUTROPHIL ELASTASE CONTRIBUTES TO LOSS OF FUNCTION OF INFLIXIMAB IN ULCERATIVE COLITIS |
14 |
|
OC.02.3 SMAD7 KNOCKDOWN RESTORES ARYL HYDROCARBON RECEPTOR EXPRESSION AND PROTECTIVE SIGNALS IN INFLAMMATORY BOWEL DISEASE |
15 |
|
OC.02.4 OXIDATIVE STRESS AND THROMBOXANE-DEPENDENT PLATELET ACTIVATION IN INFLAMMATORY BOWEL DISEASE (IBD): EFFECTS OF ANTI-TNF-ALFA TREATMENT |
15 |
|
OC.02.5 EXPERIMENTAL COMPARISON BETWEEN TWO MARKERS OF INTESTINAL INFLAMMATION, HMGB1 AND FECAL CALPROTECTIN, IN INFLAMMATORY BOWEL DISEASES |
16 |
|
OC.02.6 IDENTIFICATION OF A CUT-OFF FOR PERSISTENT ANTIINFLIXIMAB ANTIBODIES AS A PREDICTOR OF RESPONSE TO INFLIXIMAB MONOTHERAPY |
16 |
|
OC.02.7 ADALIMUMAB TROUGH LEVELS AT WEEK EIGHT AS PREDICTIVE FACTOR OF LONG TERM CLINICAL REMISSION |
16 |
|
OC.02.8 A PROSPECTIVE “REAL LIFE” STUDY ON ADALIMUMAB EFFICACY IN STEROID-DEPENDENT CROHN’S DISEASE PATIENTS: RESULTS FROM A LONG TERM FOLLOW-UP |
17 |
|
OC.02.9 CROSS-SECTIONAL EVALUATION OF TRANSMURAL HEALING IN PATIENTS WITH CROHN’S DISEASE ON MAINTENANCE TREATMENT WITH BIOLOGICS |
17 |
|
OC.02.10 ADHERENCE OF ITALIAN GASTROENTEROLOGISTS TO GUIDELINES FOR THE MANAGEMENT OF ULCERATIVE COLITIS: A MULTICENTRE PROSPECTIVE OBSERVATIONAL ITALIAN AIGO STUDY |
18 |
|
OC.03 Liver |
18 |
|
OC.03.1 QUANTIFICATION OF SERUM HBSAG IS A USEFUL PARAMETER TO OPTIMIZE ANTIVIRAL NUC THERAPY IN CHRONIC HBV INFECTION |
18 |
|
OC.03.1 QUANTIFICATION OF SERUM HBSAG IS A USEFUL PARAMETER TO OPTIMIZE ANTIVIRAL NUC THERAPY IN CHRONIC HBV INFECTION |
19 |
|
OC.03.3 NUNA NUTRITIONAL NAVIGATOR SMARTPHONE FREE APPLICATION FOR IMPROVING ADHERENCE TO MEDITERRANEAN DIET AND REDUCING BODY WEIGHT IN NON-ALCOHOLIC FATTY LIVER DISEASE PATIENTS: A PILOT STUDY |
19 |
|
OC.03.4 EFFICACY AND SAFETY OF OBETICHOLIC ACID IN PATIENTS WITH PRIMARY BILIARY CIRRHOSIS: AN ANALYSIS OF THE ITALIAN PATIENTS FROM A PHASE 3, RANDOMIZED, PLACEBOCONTROLLED STUDY |
20 |
|
OC.03.5 COGNITIVE IMPAIRMENT PREDICTS THE OCCURRENCE OF HEPATIC ENCEPHALOPATHY AFTER TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT |
20 |
|
OC.03.6 ANTICOAGULATION THERAPY FOR NON MALIGNANT PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS: A SAFE TREATMENT? |
21 |
|
OC.03.7 CIRCULATING MICROPARTICLES AND RISK OF PORTAL VEIN THROMBOSIS IN PATIENTS WITH LIVER CIRRHOSIS AND HEPATOCELLULAR CARCINOMA |
21 |
|
OC.03.8 DRUG-ELUTING BEADS VERSUS CONVENTIONAL CHEMOEMBOLIZATION FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA: A META-ANALYSIS |
21 |
|
OC.03.9 SPONTANEOUS BACTERIAL PERITONITIS (SBP) IS NOT ASSOCIATED WITH HIGHER MORTALITY IF COMPARED WITH OTHER INFECTIONS IN PATIENTS AWAITING LIVER TRANSPLANTATION (LT) |
22 |
|
OC.04 Colon Cancer |
22 |
|
OC.04.1 SMAD7 KNOCKDOWN IN COLON CANCER CELLS ACTIVATES PROTEIN KINASE RNA-ASSOCIATED EIF2-ALPHA PATHWAY THEREBY LEADING TO CELL DEATH |
22 |
|
OC.04.2 GENETIC DIVERSITY OF THE KIR/HLA SYSTEM AND OUTCOME OF PATIENTS WITH METASTATIC COLORECTAL CANCER TREATED WITH CHEMOTHERAPY |
22 |
|
OC.04.3 EXPRESSION OF TBET AND RORGAMMA-T IN REGULATORY T CELLS INFLUENCE THE INCIDENCE AND SIZE OF TUMOR MASSES IN A CAC MODEL |
23 |
|
OC.04.4 FROM INFLAMMATORY BOWEL DISEASE TO COLON CANCER: WHAT IS THE ROLE OF INFILTRATING IMMUNE CELLS? |
23 |
|
OC.04.5 RECURRENCE AFTER ENDOSCOPIC RESECTION OF ADVANCED COLORECTAL ADENOMA: A RECURSIVE PARTITIONING ANALYSIS OF PREDICTIVE FACTORS |
23 |
|
OC.04.6 EARLY DETECTION OF METACHRONOUS COLORECTAL CANCER: THE ROLE OF FATTY ACID SYNTHASE (FASN) |
24 |
|
OC.04.7 IDENTIFICATION OF PROTEOMIC PROFILES ASSOCIATED WITH TUMOR REGRESSION GRADING IN RECTAL CANCER |
24 |
|
OC.04.7 IDENTIFICATION OF PROTEOMIC PROFILES ASSOCIATED WITH TUMOR REGRESSION GRADING IN RECTAL CANCER |
25 |
|
OC.04.9 SURVEILLANCE PROTOCOL FOR ABDOMINAL DESMOID TUMOURS IN FAMILIAL ADENOMATOUS POLYPOSIS (FAP): EXPERIENCE OF A REGIONAL REFERRAL CENTRE |
25 |
|
OC.05 Esophagus |
25 |
|
OC.05.1 PROLONGED INTRA-ESOPHAGEAL PH PROFILE AND ESOPHAGEAL MOTILITY IN CHILDREN WITH EOSINOPHILIC ESOPHAGITIS |
25 |
|
OC.05.2 HIGH RESOLUTION MANOMETRY AND CLINICAL CHARACTERISTICS OF PATIENTS WITH OUTFLOW OBSTRUCTION: IS THIS A TRULY RELEVANT NOVEL MANOMETRIC DIAGNOSIS? |
26 |
|
OC.05.3 NERD AND PH CYCLICAL FLUCTUATION: PROPOSED OF THE IDEAL DIAGNOSTIC ALGORITHM |
26 |
|
OC.05.4 YIELD OF PROLONGED WIRELESS PH MONITORING IN 24 TREATED ACHALASIA PATIENTS: RETROSPECTIVE ANALYSIS |
27 |
|
OC.05.5 ROLE OF HIGH RESOLUTION MANOMETRY FINDINGS AND OF GASTRO-ESOPHAGEAL REFLUX DISEASE IN PATIENTS WITH NON OBSTRUCTIVE DYSPHAGIA |
27 |
|
OC.05.6 CLINICAL CHARACTERISTICS AND OUTCOMES OF POEM ACCORDING TO ACHALASIA MANOMETRIC PATTERN. DO THE OUTCOMES OF TREATMENT DEPEND ON MANOMETRIC SUBTYPE? |
28 |
|
OC.05.8 ESOPHAGO-GASTRIC JUNCTION MORPHOLOGY VARIABILITY DURING STANDARD MANOMETRIC PROTOCOL AND AFTER ESOPHAGEAL STIMULATION AND BODY CHANGE POSITION – PRELIMINARY RESULTS |
29 |
|
OC.05.9 LONG VS SHORT POEM FOR THE TREATMENT OF ACHALASIA. INTERIM ANALYSIS OF A RANDOMIZED CONTROLLED TRIAL |
29 |
|
OC.06 Miscellanea 1 |
30 |
|
OC.06.1 ANALYSIS OF THE EFFICACY OF OCA IN PRIMARY BILIARY CIRRHOSIS BY VARYING PATIENT DISEASE SEVERITY ACROSS THREE RANDOMIZED DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIALS |
30 |
|
OC.06.2 PANCREATIC CANCER IN WOMEN: LATE ONSET OF MENOPAUSE, USE OF HORMONE REPLACEMENT THERAPY AND TWO-PARITY ARE PROTECTIVE FACTORS |
30 |
|
OC.06.3 PROTECTIVE ACTIVITY OF LACTOBACILLUS RHAMNOSUS GGDERIVED FACTORS ON PATHOGEN LIPOPOLYSACCHARIDE (LPS)- INDUCED DAMAGE OF HUMAN COLONIC SMOOTH MUSCLE CELLS |
30 |
|
OC.06.4 THE OCCURRENCE OF POSTPRANDIAL SYMPTOMS IN IRRITABLE BOWEL SYNDROME IS ASSOCIATED WITH A REDUCTION OF POSTPRANDIAL SENSITIVITY THRESHOLDS |
31 |
|
OC.06.5 ASSESSING THE RATE OF INCORRECT DIAGNOSIS OF CELIAC DISEASE: DATA FROM A TERTIARY REFERRAL CENTER |
31 |
|
OC.06.6 EFFECTS OF MODIFIED WHEAT GLUTEN ADMINISTRATION IN PATIENTS WITH CELIAC DISEASE: RESULTS OF A DOUBLE-BLIND, GLUTEN-CONTROLLED CLINICAL TRIAL |
32 |
|
OC.06.7 RISK OF MISDIAGNOSIS AND OVERTREATMENT IN PATIENTS WITH MAIN PANCREATIC DUCT DILATATION AND SUSPECTED COMBINED/MAIN-DUCT IPMNS |
32 |
|
OC.06.8 INTEGRATED ANALYSIS OF EFFICACY OF PHASE II AND III DATA OF OBETICHOLIC ACID IN PBC SUBPOPULATIONS BASED ON AGE AND SEX |
32 |
|
OC.06.9 IRRITABLE BOWEL SYNDROME: RESULTS OF AIGO SURVEY 20142015 |
33 |
|
OC.07 UPPER GI |
34 |
|
OC.07.1 REFRACTORY PATIENTS WITH NON-ACID REFLUX DISEASE AND THOSE WITH EROSIVE AND NON-EROSIVE REFLUX DISEASE HAVE SIMILAR RESPONSE TO ANTI-REFLUX SURGICAL THERAPY |
34 |
|
OC.07.2 FUNCTIONAL HEARTBURN OVERLAPS WITH IRRITABLE BOWEL SYNDROME MORE OFTEN THAN GERD. DEVELOPMENT OF PREDICTIVE MODELS WITH NOMOGRAMS |
34 |
|
OC.07.3 RECOVERY OF GASTRIC FUNCTION AFTER ACETIUM® ADMINISTRATION: A 2 YEAR PROSPECTIVE STUDY IN PATIENTS WITH CHRONIC, ATROPHIC, BODY GASTRITIS |
35 |
|
OC.07.4 GASTROESOPHAGEAL REFLUX DISEASE BEFORE AND AFTER LAPAROSCOPIC SLEEVE GASTRECTOMY: LONG TERM RESULTS |
35 |
|
OC.07.5 GASTROINTESTINAL SYMPTOMS AND DYSPEPSIA IN AUTOIMMUNE GASTRITIS: AN OVERLOOKED OCCURRENCE |
36 |
|
OC.07.6 SERUM BIOMARKERS CAN IDENTIFY PATIENTS WITH AUTOIMMUNE AND H.PYLORI-RELATED ATROPHIC GASTRITIS AND DIFFERENTIATE THOSE WITH ADVANCED GASTRIC CHANGES |
36 |
|
OC.07.7 INSULIN-MEDIATED ESOPHAGEAL ADENOCARCINOMA DEVELOPMENT RELATED TO CHRONIC DUODENUM-ESOPHAGEAL REFLUX IN A HYPERINSULINEMIC AND NON-OBESE MURINE MODEL |
36 |
|
OC.07.8 COMBINED USE OF SERUM MARKERS AND MORPHOLOGICAL EVALUATION IN EARLY CHRONIC ATROPHIC GASTRITIS DETECTION: PRELIMINARY RESULTS |
37 |
|
OC.07.9 POTENTIAL AUTOIMMUNE ATROPHIC GASTRITIS |
37 |
|
OC.08 Endoscopy 2 |
38 |
|
OC.08.2 A SINGLE CENTER EXPERIENCE OF NOVEL LUMEN-APPOSING METAL STENT FOR ENDOSCOPIC ULTRASOUND-GUIDED DRAINAGE |
38 |
|
OC.08.3 DYSPEPTIC PATIENTS WITH NEGATIVE GASTROSCOPY HAVE HIGHER PREVALENCE OF H. PYLORI INFECTION THAN PATIENTS WITH ENDOSCOPIC LESIONS |
39 |
|
OC.08.4 ENDOSCOPIC PAPILLECTOMY: A SINGLE ITALIAN CENTRE EXPERIENCE |
39 |
|
OC.08.5 HAVE INTRAVENOUS PROTON PUMP INHIBITORS BETTER CLINICAL OUTCOME RESPECT TO ORAL PPI IN PATIENTS WITH PEPTIC ULCER BLEEDING: A META-ANALYSIS |
40 |
|
OC.08.6 EVALUATION OF A NEW THERAPEUTIC LASER SYSTEM FOR ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD) IN AN ESTABLISHED ANIMAL MODEL |
40 |
|
OC.08.7 BILIARY STENT DOES NOT INFLUENCE THE ADEQUACY AND ACCURACY OF EUS-GUIDED TISSUE ACQUISITION WITH FENESTRATED NEEDLES OF PANCREATIC MASSES CAUSING OBSTRUCTIVE JAUNDICE |
40 |
|
OC.08.8 ENDOSCOPIC PAPILLARY LARGE BALLOON DILATION FOR LARGE STONES EXTRACTION IN PATIENTS WITH PERI-AMPULLARY DIVERTICULA |
41 |
|
OC.09 Basic Science |
42 |
|
OC.09.1 TRANSGLUTAMINASE 2 (TG2) MEDIATES THE CYTOTOXIC EFFECT OF RESVERATROL IN CHOLANGIOCARCINOMA (CC) CELL LINES |
42 |
|
OC.09.2 THE EXTRACELLULAR MATRIX PROTEIN EMILIN2 AS A REGULATOR OF THE MYELOID RESPONSE IN A MODEL OF INFLAMMATION-INDUCED COLON CARCINOGENESIS |
42 |
|
OC.09.3 PALMITOYLETHANOLAMIDE (PEA) REDUCES COLITIS-INDUCED ANGIOGENESIS THROUGH AKT/MTOR PATHWAY INHIBITION |
43 |
|
OC.09.4 EXPRESSION OF THE ACTIVATED FORM OF AMPK IS REDUCED IN IBD BUT SELECTIVE ACTIVATION OF THIS KINASE IS NOT SUFFICIENT TO REVERT INTESTINAL INFLAMMATION |
43 |
|
OC.09.5 GENERATION AND FUNCTIONAL CHARACTERIZATION OF HUMAN INKT CELL LINES AND CLONES FROM HEALTHY AND INFLAMED INTESTINE |
43 |
|
OC.09.6 PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA AGONIST REDUCES THE DEVELOPMENT OF NECROTIZING ENTEROCOLITIS IN A NEONATAL RAT MODEL |
44 |
|
OC.09.7 INHIBITION OF THE MITOCHONDRIAL ATP SYNTHASE PROMOTES T CELL APOPTOSIS AND SUPPRESSES INTESTINAL INFLAMMATION |
44 |
|
OC.09.8 INTERLEUKIN-34 INDUCES CC-CHEMOKINE LIGAND 20 IN GUT EPITHELIAL CELLS |
45 |
|
OC.09.9 PROTECTIVE EFFECT OF INULIN ON LPS-INDUCED INTESTINAL SMOOTH MUSCLE IMPAIRMENT: A PROTEOMIC APPROACH |
45 |
|
OC.10 Endoscopy 3 |
45 |
|
OC.10.1 DILATION-ASSISTED STONE EXTRACTION AS ALTERNATIVE, EFFECTIVE AND SAFE METHOD FOR REMOVAL OF COMMON BILE DUCT LARGE STONES: DATA FROM A REFERRAL CENTER |
45 |
|
OC.10.2 QUALITY EVALUATION AND PROFESSIONAL ACCREDITATION IN DIGESTIVE ENDOSCOPY. PRELIMINARY DATA ACQUIRED THROUGH PEER-REVIEWED SITE VISITS |
46 |
|
OC.10.3 MID TERM RESULTS OF SECOND POEM FOR RECURRENT ACHALASIA: DATA FROM A LARGE COHORT OF PATIENTS |
46 |
|
OC.10.4 PROSPECTIVE COMMUNITY PRACTICE-BASED STUDY OF ERCP QUALITY |
47 |
|
OC.10.5 FULLY COVERED SELF-EXPANDABLE METAL STENTS TO DILATE PANCREATIC DUCT STRICTURES DUE TO CHRONIC PANCREATITIS: A PILOT STUDY |
47 |
|
OC.10.6 POST-SPHINCTEROTOMY TRANSPAPILLARY BALLOON DILATION FOR REMOVAL OF LARGE BILE DUCT STONE IS MORE EFFECTIVE AND SAFE COMPARED TO ENDOSCOPIC SPHINCTEROTOMY? A META-ANALYSIS |
48 |
|
OC.10.7 IMPACT OF BOWEL LAVAGE ON GUT MICROBIOTA |
48 |
|
OC.10.8 PREDICTION OF TECHNICAL DIFFICULTY OF COLORECTAL ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD): PROSPECTIVE STUDY TO FAVOR ITS PRACTICE IN THE WEST |
48 |
|
OC.10.9 DETECTION OF COLONIC ADENOMAS USING DIFFERENT COLONOSCOPY INSERTION TECHNIQUES |
49 |
|
OC.11 IBD 2 |
50 |
|
OC.11.1 INFLAMMATORY BOWEL DISEASE PHENOTYPE AS RISK FACTOR FOR CANCER IN A PROSPECTIVE MULTICENTER NESTED CASECONTROL IG-IBD STUDY |
50 |
|
OC.11.2 CROHN’S DISEASE-ASSOCIATED SMALL BOWEL CARCINOMAS SHOW DISTINCTIVE HISTOLOGY AND PHENOTYPE IN COMPARISON TO SPORADIC CASES: AN ITALIAN MULTICENTRE STUDY |
50 |
|
OC.11.3 DISEASE COURSE AND COLECTOMY RATE IN ULCERATIVE COLITIS: A FOLLOW-UP COHORT STUDY OF A REFERRAL CENTER IN TUSCANY |
51 |
|
OC.11.4 FOOD PRESERVATIVES AND ADDITIVES EXACERBATE INTESTINAL INFLAMMATION |
51 |
|
OC.11.5 VITAMIN D DEFICIENCY IN EXPERIMENTAL CD-LIKE ILEITIS: A PRELIMINARY STUDY |
51 |
|
OC.11.6 LOCALIZATION OF EBV IN COLONIC MUCOSAL CELLS OF IBD PATIENTS AND CORRELATION WITH DISEASE ACTIVITY INDEXES |
52 |
|
OC.11.7 MOTIVATIONAL INTERVIEWING IN OUTPATIENTS COUNSELLING: DATA FROM A LARGE CASE-CONTROL STUDY IN INFLAMMATORY BOWEL DISEASE PATIENTS |
52 |
|
OC.11.8 EFFICACY OF A “CALL CENTER-BASED COMMUNICATION” IN OPTIMIZING THE CARE OF INFLAMMATORY BOWEL DISEASES |
53 |
|
OC.11.9 IBD-NURSE IN PATIENTS’ HEALTH STATUS ASSESSMENT: DATA FROM A PILOT STUDY COMPARING ABILITY OF IBD-NURSE AND GASTROENTEROLOGIST IN USING IBD-CLINICAL SCORES |
53 |
|
OC.12 Miscellanea 2 |
54 |
|
OC.12.1 ARE BASELINE IMPEDANCE LEVELS ASSESSED DURING ESOPHAGEAL IMPEDANCE MANOMETRY HELPFUL IN DISCRIMINATING PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE FROM THOSE WITHOUT? A PILOT STUDY |
54 |
|
OC.12.2 HLA TESTING IN ADULT-ONSET CELIAC DESEASE: RELATIONSHIP WITH CLINICAL PRESENTATION AND MUCOSAL DAMAGE |
54 |
|
OC.12.3 SUSTAINED IMPROVEMENT OF A CASE WITH REFRACTORY CELIAC DISEASE (RCD) BY SERIAL INFUSIONS OF AUTOLOGOUS BONE MARROW-DERIVED MESENCHYMAL STEM CELLS |
54 |
|
OC.12.4 TEMPOROMANDIBULAR DISORDERS (TMD) IN PATIENTS WITH IRRITABLE BOWEL SYNDROME (IBS) |
55 |
|
OC.12.5 ESOPHAGEAL SHORTENING IS ASSOCIATED TO SWALLOWINDUCED LES RELAXATION AND INCOMPLETE TLES RELAXATIONS IN NERD PATIENTS AND HEALTHY CONTROLS |
55 |
|
OC.12.6 THE ROLE OF S100B IN THE DEVELOPING ENTERIC NERVOUS SYSTEM |
56 |
|
OC.12.7 BILE DUCT INVOLVEMENT IN AUTOIMMUNE PANCREATITIS: CLINICAL FEATURES AND PROGNOSTIC ASPECTS IN 92 PATIENTS |
56 |
|
OC.12.8 LONG-TERM SAFETY OF OBETICHOLIC ACID IN PATIENTS WITH PRIMARY BILIARY CIRRHOSIS |
56 |
|
OC.12.9 FECAL MICROBIOTA TRANSPLANTATION FOR RECURRENT C. DIFFICILE INFECTION: A 2-YEAR EXPERIENCE FROM A EUROPEAN REFERRAL CENTRE |
57 |
|
V.01 Video 1 |
58 |
|
V.01.1 GASTROSCOPIC REMOVAL OF A MIGRATED ADJUSTABLE GASTRIC BAND: A CASE REPORT |
58 |
|
V.01.1 GASTROSCOPIC REMOVAL OF A MIGRATED ADJUSTABLE GASTRIC BAND: A CASE REPORT |
58 |
|
V.01.3 ENDOSCOPIC BANDING FOR ABLATION OF DUODENAL FLAT LESIONS IN HIGH RISK PATIENTS |
58 |
|
V.01.4 EUS-GUIDED DRAINAGE OF AN INFECTED PANCREATIC PSEUDOCYST AND SUCCESSIVE TREATMENT WITH HEMOSTATIC POWDER FOR A LATE INTRACYSTIC BLEEDING |
59 |
|
V.01.5 A SIMPLE AND SAFE METHOD FOR REMOVAL OF AN ESOPHAGEAL FISTULIZING FULLY-COVERED SELF-EXPANDING METAL STENT |
59 |
|
V.01.6 STONE IMPACTION IN THE PAPILLA: IS AN URGENT ERCP INDICATED? |
59 |
|
V.01.7 ENDOSCOPIC ULTRASOUND-GUIDED SINGLE-INCISION WITH NEEDLE KNIFE AND DEEP TISSUE BIOPSY FOR THE DIAGNOSIS OF A GASTRIC SUBEPITHELIAL TUMOR |
60 |
|
V.01.8 HAEMOSTATIC TREATMENT WITH A NEW THERAPEUTIC LASER SYSTEM – FIRST IN VIVO EXPERIENCE (WITH VIDEO) |
60 |
|
V.01.9 ENDOSCOPIC CLOSURE OF IATROGENIC DUODENAL PERFORATION SUCCESSFULLY TREATED WITH A NEW OVER-THESCOPE CLIP |
61 |
|
V.01.10 “DISSECTING THE STONE”: SUCCESSFUL ENDOSCOPIC “LITHO HYDRO-JET TRIPSY, LHJT” OF A BOUVERET SYNDROME |
61 |
|
V.01.11 IN VIVO ASSESSMENT OF TUMOR ANGIOGENESIS IN COLORECTAL CANCER: ROLE OF CONFOCAL LASER ENDOMICROSCOPY |
62 |
|
V.01.12 OVER-THE-SCOPE CLIP-ASSISTED ENDOSCOPIC FULL THICKNESS RESECTION AFTER INCOMPLETE RESECTION OF RECTAL ADENOCARCINOMA: CASE AND VIDEO REPORT |
62 |
|
V.01.13 ENDOSCOPIC LIGATION AND RESECTION OF A LARGE SYMPTOMATIC SUBEPITHELIAL TUMOR OF THE DUODENUM |
62 |
|
V.02 Video 2 |
63 |
|
V.02.1 4 CASES OF ENDOSCOPIC FULL-THICKNESS RESECTION OF COLONIC LESIONS USING OVESCO FTRD® SYSTEM: OUR EXPERIENCE |
63 |
|
V.02.2 ENDOSCOPIC ULTRASOUND GUIDED RADIOFREQUENCY ABLATION OF A PANCREATIC NEUROENDOCRINE TUMOUR (WITH VIDEO) |
63 |
|
V.02.3 WALLED-OFF PANCREATIC NECROSIS: THE NEW ERA OF ENDOSCOPIC TREATMENT |
64 |
|
V.02.4 NOVEL SINGLE OPERATOR DIGITAL COLANGIOSCOPE FOR A DIAGNOSIS OF CYSTIC DUCT CARCINOMA: A CASE REPORT |
64 |
|
V.02.4 NOVEL SINGLE OPERATOR DIGITAL COLANGIOSCOPE FOR A DIAGNOSIS OF CYSTIC DUCT CARCINOMA: A CASE REPORT |
64 |
|
V.02.6 ENDOSCOPIC SUBMUCOSAL DISSECTION OF A LARGE PSEUDODEPRESSED SUPERFICIAL NEOPLASM OF THE TERMINAL ILEUM |
65 |
|
V.02.7 ENDOSCOPIC RESECTION OF A LARGE PYLORIC GLAND ADENOMA OF THE CARDIA |
65 |
|
V.02.8 EFFECTIVE ENDOSCOPIC HOLMIUM LASER LITHOTRIPSY IN THE TREATMENT OF A LARGE IMPACTED GALLSTONE IN THE DUODENUM |
65 |
|
V.02.9 AN INDETERMINATE BILIARY STRICTURES ASSESSED USING THE NEXT GENERATION SPYGLASS DS SYSTEM: A VIDEO CASE |
66 |
|
V.02.10 AN INNOVATIVE EVALUATION OF PANCREATIC CYSTS BY CONFOCAL LASER ENDOMICROSCOPY AND FIBER OPTIC LIGHTING DIRECT VISUALIZATION SYSTEM |
66 |
|
V.02.13 METASTATIC MELANOMA OF THE GALLBLADDER DIAGNOSED BY ENDOSCOPIC ULTRASOUND-GUIDED FINE NEEDLE BIOPSY |
67 |
|
V.02.14 THE DIAGNOSIS OF AMOEBIC COLITIS IN NORTHERN ITALY: NOT AN EASY TASK! |
68 |
|
Posters |
69 |
|
P.01 Liver 1 |
69 |
|
P.01.1 A SINGLE INFUSION OF FERRIC CARBOXYMALTOSE EFFECTIVELY IMPROVES IRON-DEFICIENCY ANEMIA IN PATIENTS WITH GASTROINTESTINAL AND LIVER DISEASE: A HOSPITAL-BASED SURVEY |
69 |
|
P.01.2 HBV INFECTION PREVALENCE AND VACCINATION IN AN IMMIGRANT POPULATION IN ROME |
69 |
|
P.01.3 EFFICACY OF MEDITERRANEAN DIET AND ANTIOXIDANTS IN OVERWEIGHT PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE |
69 |
|
P.01.4 ENDOCAN AS SERUM MARKER OF ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE AND/ OR TYPE 2 DIABETES |
70 |
|
P.01.5 NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AS POTENTIAL RISK FACTOR OF CARDIOVASCULAR DISEASE AND ONCOLOGICAL DISEASE IN DIABETIC TYPE 2 PATIENTS |
70 |
|
P.01.6 HEPATIC ENCEPHALOPATHY IS ASSOCIATED WITH PERSISTENT COGNITIVE DEFICITS DESPITE ADEQUATE MEDICAL TREATMENT: A MULTI-CENTER, INTERNATIONAL STUDY |
70 |
|
P.01.7 MICROWAVE ABLATION OF LARGE HCCS BY SIMULTANEOUS MULTIPLE ANTENNAE INSERTION: LONG TERM FOLLOW-UP |
71 |
|
P.01.8 PERCUTANEOUS ELECTROCHEMOTHERAPY OF MALIGNANT MAIN PORTAL VEINS THROMBOSIS: A PROSPECTIVE CASE SERIES |
72 |
|
P.01.9 THE GUT MICROBIOTA OF CIRRHOTIC PATIENTS WITH POOR NUTRITIONAL STATUS: PRELIMINARY EVIDENCES |
72 |
|
P.01.10 CLINICAL OUTCOME OF IMMUNOSUPPRESSION IN PATIENTS WITH AUTOIMMUNE HEPATITIS: A SICILIAN COHORT STUDY |
73 |
|
P.02 Pancreas |
73 |
|
P.02.1 VITAMIN D DEFICIENCY AS A RISK FACTOR IN PANCREATIC NEUROENDOCRINE NEOPLASMS: REPORT FROM A SERIES AT A SINGLE INSTITUTE |
73 |
|
P.02.2 SYSTEMATIC REVIEW AND META-ANALYSIS: PREVALENCE OF INCIDENTALLY DETECTED PANCREATIC CYSTIC LESIONS IN ASYMPTOMATIC INDIVIDUALS |
73 |
|
P.02.3 ASPIRIN, STATINS AND PANCREATIC CANCER: IS THERE ROOM FOR CHEMOPREVENTION? |
74 |
|
P.02.4 REASSESSMENT OF HISTOLOGICAL FEATURES AT DISEASE PROGRESSION DURING THE FOLLOW-UP OF NEUROENDOCRINE TUMOURS |
74 |
|
P.02.5 PREVALENCE OF CHRONIC PANCREATITIS IN THE PRIMARY CARE SETTING |
74 |
|
P.02.6 ACUTE PANCREATITIS IN CAMPANIA: PROPOSALS FOR A RESOURCES SAVING REGIONAL ORGANIZATION |
75 |
|
P.02.7 FREQUENCY AND CLINICAL-INSTRUMENTAL CHARACTERIZATION OF ACUTE PANCREATITIS FROM HYPERTRIGLYCERIDEMIA IN A CONSECUTIVE SERIES OF 105 PATIENTS |
75 |
|
P.02.9 ELASTPQ-POINT SHARE WAVE ELASTOGRAPHY (ELASTPQ®- PSWE) IN CHRONIC PANCREATITIS. A PROMISING TOOL FOR STAGING DISEASE SEVERITY |
76 |
|
P.02.10 CLINICAL AND RADIOLOGICAL FEATURES OF 40 PATIENTS WITH SEROUS CYSTADENOMA OF THE PANCREAS |
76 |
|
P.02.11 EXOCRINE PANCREATIC INSUFFICIENCY IN INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM (IPMN) WITH WIDESPREAD GLANDULAR INVOLVEMENT |
76 |
|
P.02.12 THE USE OF COMPLEMENTARY AND ALTERNATIVE MEDICINE IS FREQUENT IN PATIENTS WITH PANCREATIC DISORDERS |
77 |
|
P.02.13 INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS (IPMNS): RESULTS OF A THREE-YEAR FOLLOW-UP STUDY |
77 |
|
P.02.14 ACUTE PANCREATITIS IN ELDERLY PATIENTS: A RETROSPECTIVE EVALUATION AT HOSPITAL ADMISSION |
78 |
|
P.03 Endo/EUS 1 |
78 |
|
P.03.1 DIAGNOSTIC ACCURACY AND THERAPEUTIC IMPACT OF EUS IN PATIENTS WITH INTERMEDIATE SUSPICION OF CHOLEDOCHOLITHIASIS AND NEGATIVE MRCP |
78 |
|
P.03.2 IS THERE A LINK BETWEEN PERIAMPULLARY DIVERTICULA AND BILIOPANCREATIC DISEASES? AN EUS APPROACH TO ANSWER THE QUESTION |
78 |
|
P.03.3 USEFULNESS OF ENDOSCOPIC ULTRASONOGRAPHY TO GUIDE THE RATIONAL USE OF ERCP: STRATIFY THE LIKELIHOOD OF CHOLEDOCHOLITHIASIS IN THE CLINICAL SUSPICION OF PERSISTENT BILE DUCT STONE |
79 |
|
P.03.4 ENDOSCOPIC ULTRASOUND-GUIDED BILIARY DRAINAGE FOR MALIGNANT BILIARY OBSTRUCTION AFTER FAILED ERCP: A SINGLE ITALIAN CENTER EXPERIENCE |
79 |
|
P.03.5 REPETITION OR SIMULTANEOUS SAMPLING OF PRIMARY AND METASTATIC LESIONS IMPROVE DIAGNOSTIC ACCURACY OF EUS-FNA IN THE ASSESSMENT OF SUSPECTED NEOPLASTIC PANCREATIC MASS |
80 |
|
P.03.6 COMPARING EUS-FNA AND ERCP-BRUSHING IN THE DIAGNOSTIC WORKOUT OF SUSPECTED CHOLANGIOCARCINOMA: A RETROSPECTIVE SINGLE-CENTER ANALYSIS |
80 |
|
P.03.7 EUS-GUIDED FINE NEEDLE ASPIRATION OF SOLID PANCREATIC TUMORS IN YOUNG PATIENTS: EXPERIENCE IN A TERTIARY REFERRAL CENTER |
80 |
|
P.03.8 ACCESSING TO THE LEFT PARATRACHEAL (#4L) AND THE AORTOPULMONARY WINDOW (#5) MEDIASTINAL LYMPH NODES BY ENDOSCOPIC ULTRASOUND WITH FINE NEEDLE ASPIRATION (EUS-FNA) |
81 |
|
P.03.9 IS ENDOSCOPIC ULTRASONOGRAPHY USEFUL IN SUBJECTS HAVING ASYMPTOMATIC CHRONIC PANCREATIC HYPERENZYMEMIA? |
81 |
|
P.04 Upper GI Disorders |
81 |
|
P.04.1 CORRELATION BETWEEN SEASONAL EXACERBATIONS OF UPPER GI SYMPTOMS AND NUMBER OF 13C-UREA BREATH TESTS PERFORMED IN A LARGE UNIVERSITY HOSPITAL |
81 |
|
P.04.2 MORPHO-FUNCTIONAL MODIFICATIONS OF THE GASTRIC REMNANT AFTER ROUX-EN-Y GASTRIC BYPASS (RYGB): THE (NOT SO) SPLEEPING REMNANT? |
82 |
|
P.04.3 SERUM PEPSINOGEN II LEVELS AND IGG ANTI HELICOBACTER PYLORI ANTIBODIES MAY REPRESENT A NON-INVASIVE METHOD FOR THE DIAGNOSIS AND MONITORING OF H PYLORI-RELATED GASTRITIS |
82 |
|
P.04.4 THE SHOWER IS NOT WARM ENOUGH! |
83 |
|
P.04.5 PROGNOSIS OF GASTRIC GISTS BASED ON TUMOR SIZE |
83 |
|
P.04.6 PREVALENCE OF H. PYLORI INFECTION IN SEXUAL PARTNERS OF H. PYLORI INFECTED SUBJECTS: ROLE OF GASTROESOPHAGEAL REFLUX |
84 |
|
P.04.7 PREVALENCE OF H. PYLORI INFECTION AMONG PATIENTS COMING FROM DIFFERENT COUNTRIES AND LIVING IN ROME AREA |
84 |
|
P.04.8 PREVALENCE OF H. PYLORI INFECTION IN A POPULATION OF ITALIANS AND IMMIGRANTS IN ROME AND RATE OF RESPONSE TO THERAPY |
84 |
|
P.04.9 DIAGNOSIS OF CHRONIC ATROPHIC GASTRITIS IN PRIMARY CARE SETTING BY MEANS OF GASTROPANEL®: A POPULATION STUDY ON 10,000 CONSECUTIVE PATIENTS |
85 |
|
P.04.10 GASTRIC CANCER AND SIMULTANEOUS CARE: PRELIMINARY REPORT ABOUT THE TAKE CHARGE APPROACH |
85 |
|
P.05 Clinical Cases |
85 |
|
P.05.1 ENDOSCOPIC REMOVAL OF A LARGE SYMPTOMATIC IMPACTED BONE IN THE COLON |
85 |
|
P.05.2 FIRST CASE OF SMALL BOWEL ADENOCARCINOMA DETECTED WITH THE NEW 360° PANORAMIC-VIEWING CAPSULE ENDOSCOPY SYSTEM |
86 |
|
P.05.3 A RARE CASE OF GASTROINTESTINAL BLEEDING |
86 |
|
P.05.4 A RARE CASE OF MIXED ADENO-NEUROENDOCRINE GASTRIC CARCINOMA (MANEC) ASSOCIATED TO AUTOIMMUNE METAPLASTIC ATROPHIC GASTRITIS (AMAG) |
87 |
|
P.05.5 AN UNUSUAL CASE OF DYSPHAGIA |
87 |
|
P.05.6 A RARE CASE OF CELIAC DISEASE IN A PATIENT WITH COMMON VARIABLE IMMUNODEFICIENCY: WHEN VILLOUS ATROPHY IS NOT ENOUGH |
88 |
|
P.05.7 SYSTEMATIC REVIEW AND META-ANALYSIS OF STUDIES COMPARING METAL OR PLASTIC STENTS FOR PREOPERATIVE BILIARY DRAINAGE IN RESECTABLE PANCREATIC CANCER |
89 |
|
P.05.8 RECURRENT LIFE-THREATENING GASTROINTESTINAL BLEEDING DUE TO MECKEL’S DIVERTICULUM |
89 |
|
P.05.10 DUODENAL NEUROENDOCRINE TUMORS – DATA FROM A SINGLE CENTRE |
90 |
|
P.05.11 UNUSUAL ONSET OF COLONIC SARCOIDOSIS: A CASE REPORT |
90 |
|
P.05.12 DIFFUSE INTESTINAL NODULAR LYMPHOID HYPERPLASIA (DNLH) IN A PATIENT WITH EPIGASTRIC PAIN: A CASE REPORT |
91 |
|
P.05.13 PANCREATIC MUCINOUS CYSTIC ADENOCARCINOMA METASTASIS TO THE RECTUM |
91 |
|
P.05.14 MUCOSAL TEARS OCCURRED DURING COLONOSCOPY IN OUTPATIENT WITH ULCERATIVE COLITIS: A CASE REPORT |
91 |
|
P.06 Coeliac Disease 1 |
92 |
|
P.06.1 USEFULNESS OF LASER DOPPLER PERFUSION IMAGING TO OBJECTIFY THE ORAL MUCOSA PATCH TEST IN THE DIAGNOSIS OF ALLERGIC CONTACT MUCOSITIS IN NICKEL-SENSITIVE PATIENTS |
92 |
|
P.06.2 HOW MUCH DO CELIAC PATIENTS KNOW ABOUT GLUTEN FREE DIET? |
92 |
|
P.06.3 FODMAPS FREE DIET: AN EFFECTIVE SOLUTION FOR SYMPTOMATIC COELIAC PATIENTS ON GLUTEN FREE DIET |
93 |
|
P.06.4 ADULT CELIAC PATIENTS ADHERENCE TO A FOLLOW-UP PROGRAM IN THE FIRST YEAR OF GLUTEN-FREE DIET: A SINGLE CENTER STUDY |
93 |
|
P.06.5 HIGH SMAD7 IN REFRACTORY CELIAC DISEASE SUSTAINS INFLAMMATORY CYTOKINE RESPONSE |
93 |
|
P.06.6 SUBTYPES OF CHRONIC GASTRITIS IN PATIENTS WITH COELIAC DISEASE BEFORE AND AFTER GLUTEN-FREE DIET |
94 |
|
P.06.7 GLIADIN EFFECT ON THE OXIDATIVE BALANCE AND DNA DAMAGE IN CACO-2 CELL LINE |
94 |
|
P.06.8 SERUM 25-HYDROXYCHOLECALCIFEROL LEVELS AT CELIAC DISEASE DIAGNOSIS PREDICT BONE MINERAL DENSITY RECOVERY AFTER GLUTEN EXCLUSION |
94 |
|
P.06.9 VILLOUS ATROPHY WITHOUT COELIAC ANTIBODIES |
95 |
|
P.06.10 USE OF VIDEOCAPSULE ENTEROSCOPY IN COMPLICATED CELIAC DISEASE: A META-ANALYSIS |
95 |
|
P.06.11 SEVERE WHEAT ALLERGY AND CELIAC DISEASE IN THE SAME PATIENT: A DANGEROUS COEXISTENCE |
95 |
|
P.07 IBD 1 |
96 |
|
P.07.1 GUT MICROBIOTA MOLECULAR SPECTRUM IN HEALTHY CONTROLS, DIVERTICULAR DISEASE, IBS AND IBD PATIENTS: TIME FOR MICROBIAL MARKER OF GASTROINTESTINAL DISORDERS? |
96 |
|
P.07.2 BEYOND MUCOSAL HEALING: TRANSMURAL AND EXTRAMURAL HEALING AFTER ONE-YEAR ANTI-TNFA THERAPY IN CROHN’S DISEASE |
96 |
|
P.07.3 MAINTENANCE OF CLINICAL REMISSION IN IBD PATIENTS AFTER DISCONTINUATION OF ANTI-TNF AGENTS, AN ITALIAN EXPERIENCE |
97 |
|
P.07.4 HEMOGLOBIN AND FERRITIN VALUES ARE ASSOCIATED WITH INCREASED RATE OF MUCOSAL HEALING IN PATIENTS WITH CROHN’S DISEASE TREATED WITH ANTI-TNF ALPHA |
97 |
|
P.07.5 ON THE ORIGIN OF CRP IN CROHN’S DISEASE: ROLE OF THE EXTRAMURAL COMPONENT |
98 |
|
P.07.6 ROLE OF DIFFUSION-WEIGHTED IMAGING (DWI) IN MRIENTEROGRAPHY FOR THE EVALUATION OF SURGICAL RISK IN PATIENTS WITH CROHN’S DISEASE |
98 |
|
P.07.7 CROHN’S DISEASE IS A REAL TIME SENSITIVE EVOLUTIVE PATHOLOGY BASED ON LÉMANN INDEX? PRELIMINARY DATA FROM A TERTIARY PEDIATRIC IBD CENTER |
99 |
|
P.07.8 IL-33/ST2 AXIS MODULATES EPITHELIAL REPAIR AND GUT MUCOSAL WOUND HEALING IN DSS-COLITIC MICE |
99 |
|
P.07.9 EFFECTIVENESS OF PSYCHOLOGICAL SUPPORT ON QUALITY OF LIFE IN IBD PATIENTS |
99 |
|
P.07.10 FAECAL-ASSOCIATED AND MUCOSAL-ASSOCIATED MICROBIOTA IN INFLAMMATORY BOWEL DISEASE PATIENTS AND HEALTHY SUBJECTS: PRELIMINARY EVIDENCE |
100 |
|
P.07.11 ASSOCIATION BETWEEN INFLAMMATORY BOWEL DISEASE AND VITAMIN D DEFICIENCY: A SYSTEMATIC REVIEW AND METAANALYSIS |
100 |
|
P.07.12 BETA-GLUCAN, INOSITOL AND DIGESTIVE ENZYMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE ASSOCIATED WITH IRRITABLE BOWEL SYNDROME |
101 |
|
P.07.13 FOUR-YEAR EFFICACY AND SAFETY OF AZATHIOPRINE TREATMENT IN THE MAINTAINANCE OF STEROID-FREE REMISSION IN INFLAMMATORY BOWEL DISEASE PATIENTS |
101 |
|
P.07.15 INFLIXIMAB TROUGH LEVELS AND ANTI-DRUG ANTIBODIES AFTER INDUCTION AS PREDICTIVE FACTORS OF LONG TERM CLINICAL REMISSION |
102 |
|
P.07.16 PREDICTORS OF BOWEL DAMAGE AND DAMAGE PROGRESSION AS ASSESSED BY THE LÉMANN INDEX IN EVERY-DAY CLINICAL PRACTICE |
102 |
|
P.07.17 A NEW THERAPEUTIC LASER SYSTEM FOR HEMOSTATIC TREATMENTS IN GI ENDOSCOPY – FIRST RESULTS IN AN ESTABLISHED ANIMAL MODEL |
103 |
|
P.08 Esophagus |
103 |
|
P.08.1 ABNORMAL INTRA-BOLUS PRESSURE CORRELATES WITH ESOPHAGO-GASTRIC DYSFUNCTION AND ITS AGE-RELATED MODIFICATION – A STUDY USING HIGH-RESOLUTION MANOMETRY |
103 |
|
P.08.2 PROXIMAL GASTRO ESOPHAGEAL REFLUX: WHAT’S WRONG WITH GASTRO-ESOPHAGEAL MOTILITY? |
104 |
|
P.08.3 BASELINE IMPEDANCE VALUES CAN REPRESENT A MARKER OF GASTROESOPHAGEAL REFLUX DISEASE AND ARE STRONGLY RELATED WITH THE DURATION OF THE DISEASE |
104 |
|
P.08.4 INCIDENCE AND MANAGEMENT OF ACHALASIA IN CLINICAL PRACTICE: AN EIGHT-YEAR SINGLE CENTRE EXPERIENCE |
105 |
|
P.08.5 FEASIBILITY OF HIGH RESOLUTION IMPEDANCE MANOMETRY IN ASSESSING BARRETT’S ESOPHAGUS EXTENSION |
105 |
|
P.08.6 THE IMPACT OF RHINOLOGIC EVALUATION ON PATIENTS WITH SUSPECTED SUPRAESOPHAGEAL REFLUX DISEASE |
106 |
|
P.08.7 THE USE OF NON-ABLATIVE RF ENERGY (STRETTA) FOR THE TREATMENT OF GERD, WHAT HAPPENS A DECADE LATER |
106 |
|
P.08.8 CAUSAL EFFECT ASSOCIATION BETWEEN GASTROESOPHAGEAL REFLUX DISEASE AND NONALLERGIC RHINITIS WITH NEUTROPHILS |
106 |
|
P.08.9 CORRELATION BETWEEN HIGH RESOLUTION MANOMETRY PARAMETERS AND SYMPTOMS IN TREATED ACHALASIA PATIENTS |
107 |
|
P.08.10 ESOPHAGOGASTRIC JUNCTION MORPHOLOGY ASSESSMENT BY HIGH RESOLUTION MANOMETRY IN OBESE PATIENTS CANDIDATE TO BARIATRIC SURGERY |
107 |
|
P.08.11 THE POSITION WITHIN THE OESOPHAGEAL CIRCUMFERENCE PREDICTS DYSPLASIA IN SHORT SEGMENT BARRETT’S ESOPHAGUS: A 7-YEAR RETROSPECTIVE SERIES OF 341 LESIONS |
107 |
|
P.08.12 GERDQ QUESTIONNAIRE DISTINGUISHES PROTON PUMP INHIBITOR-RESPONSIVE ESOPHAGEAL EOSINOPHILIA FROM EOSINOPHILIC ESOPHAGITIS PATIENTS |
108 |
|
P.08.13 WHICH IS THE BEST CUT-OFF TO DEFINE INEFFECTIVE ESOPHAGEAL MOTILITY? |
108 |
|
P.08.14 A PROSPECTIVE APPLICATION OF THE ESPGHAN GUIDELINES IN A SYMPTOMATIC ADULT POPULATION |
109 |
|
P.08.15 INCREASED INTRA-BOLUS PRESSURE IS ASSOCIATED WITH NONCARDIAC CHEST PAIN AND NEGATIVE ENDOSCOPY – A STUDY USING HIGH-RESOLUTION MANOMETRY |
109 |
|
P.08.16 NEW IMPEDANCE-PH PARAMETERS OF GASTRO-ESOPHAGEAL REFLUX DISEASE: A LESSON FROM PATIENTS WITH CHRONIC AUTOIMMUNE ATROPHIC GASTRITIS, NON-EROSIVE REFLUX DISEASE AND FUNCTIONAL HEARTBURN |
110 |
|
P.09 Colon 1 |
110 |
|
P.09.1 HIGHER ADENOMA DETECTION RATE BUT NOT ADVANCED ADENOMA WITH ENDOCUFF-ASSISTED COLONOSCOPY IN A SCREENING POPULATION |
110 |
|
P.09.2 COLORECTAL CANCER SCREENING: PRELIMINARY DATA FROM THE CASERTA AREA |
111 |
|
P.09.3 COLORECTAL CANCER SCREENING IN EARLY AGE: PRELIMINARY DATA FROM THE CASERTA AREA |
111 |
|
P.09.4 THREE-DIMENSIONAL HIGH-RESOLUTION ANORECTAL MANOMETRY AND RECTOANAL DELTA CONTRACTILE INTEGRAL FOR THE ASSESSMENT OF FUNCTIONAL DEFECATORY DISORDERS: TOY OR TOOL? |
111 |
|
P.09.5 DIVERTICULAR DISEASE: ALTERED RESPONSE TO ENTERIC NEUROTRANSMITTERS IN HUMAN COLONIC LONGITUDINAL AND CIRCULAR SMOOTH MUSCLE |
112 |
|
P.09.6 LONG TERM FOLLOW-UP OF RECURRENT/RESIDUAL COLORECTAL ADENOMAS AFTER ENDOSCOPIC SUBMUCOSAL DISSECTION: A SINGLE CENTER EXPERIENCE |
112 |
|
P.09.8 BIOFEEDBACK BENEFITS PATIENTS WITH DYSSYNERGIC DEFECATION WITH OR WITHOUT ELECTRICAL STIMULATION |
113 |
|
P.09.9 AN APPROACH TO CHRONIC CONSTIPATION BY DIGITAL EXAMINATION + BALLOON EXPULSION TEST IS FEASIBLE IN DAILY CLINICAL PRACTICE AND DECREASES FURTHER ANORECTAL INVESTIGATION |
113 |
|
P.09.10 CLINICAL USE OF VIDEO CAPSULE ENDOSCOPY FOR SMALL BOWEL SURVEILLANCE IN HEREDITARY COLORECTAL CANCER SYNDROMES |
114 |
|
P.09.11 ASSOCIATION BETWEEN COLORECTAL POLYPS AND COLONIC DIVERTICULOSIS |
114 |
|
P.09.12 ASSESSMENT OF FECAL MICROBIOTA AND FECAL METABOLOME IN SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE OF THE COLON |
114 |
|
P.09.13 ADVANCED ADENOMA IN SCREENING POPULATION AND LIFE STYLE HABITS: A CASE CONTROL STUDY |
115 |
|
P.09.14 ROLE OF METABOLIC, ATHEROGENIC AND PSYCHOLOGICAL FACTORS IN PATIENTS WITH COLORECTAL ADENOMAS |
115 |
|
P.09.15 INCREASED ABUNDANCE OF BENEFICIAL BACTERIA IS ASSOCIATED WITH CLINICAL IMPROVEMENT AFTER RIFAXIMIN TREATMENT |
115 |
|
P.10 Liver 2 |
116 |
|
P.10.1 REACTIVATION OF HEPATITIS B VIRUS IN CANCER PATIENTS TREATED WITH CHEMOTHERAPY FOR SOLID TUMORS. IS THE PROPHYLAXIS REALLY REQUIRED? |
116 |
|
P.10.2 EFFECTS OF SILYBIN ADMINISTRATION ON THE REDOX STATE AND OXIDATIVE STRESS RESPONSE OF HUMAN ENDOTHELIAL CELLS IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS |
117 |
|
P.10.3 COUPLED PLASMA FILTRATION ADSORPTION (CPFA) REDUCES BILIRUBIN. CASE REPORT WITH A SYSTEMATIC REVIEW OF THE LITERATURE |
117 |
|
P.10.4 SPLEEN ELASTOGRAPHY WITH ACOUSTIC RADIATION FORCE IMPULSE IMAGING IN CIRRHOSIS WITH PORTAL HYPERTENSION |
117 |
|
P.10.5 BERBERINE, TOCOTRIENOLS AND GREEN DECAFFEINATED COFFEE IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE: EFFECT OF FULL AND HALF DOSE TREATMENT. SINGLECENTRE OBSERVATIONAL STUDY |
118 |
|
P.10.6 MICROWAVE ABLATION OF LARGE HCCS USING A NEW DEVICE: A CASE SERIES |
118 |
|
P.10.7 MICROWAVE ABLATION VERSUS RADIOFREQUENCY ABLATION FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS |
118 |
|
P.10.8 PREVALENCE AND RISK FACTORS OF METABOLIC SYNDROME AFTER LIVER TRANSPLANTATION: A SINGLE CENTRE EXPERIENCE |
119 |
|
P.10.9 ACCURACY OF INTESTINAL PERMEABILITY IN PREDICTING THE DEVELOPMENT OF COMPLICATIONS IN PATIENTS WITH LIVER CIRRHOSIS |
119 |
|
P.10.10 FEASIBILITY OF HCV INFECTION SCREENING IN BABY BOOMERS WITH A RAPID, NON-INVASIVE POINT-OF-CARE TEST IN ORAL FLUID |
120 |
|
P.11 Endo/EUS 2 |
120 |
|
P.11.1 EUS-GUIDED PANCREATICOGASTROSTOMY AFTER GASTRIC SURGERY WITH ROUX-EN-Y RECONSTRUCTION: A BRIEF CASE SERIES |
120 |
|
P.11.2 ENDOSCOPIC ULTRASONOGRAPHY IN THE DIAGNOSIS AND STAGING OF NEUROENDOCRINE TUMORS |
121 |
|
P.11.3 THE ROLE OF COMBINED USE OF EUS-FNA AND BILIARY BRUSHING IN CYTOLOGICAL DIAGNOSIS OF PANCREATOBILIARY MALIGNANCES |
121 |
|
P.11.4 CLINICAL IMPACT OF ENDOSCOPIC ULTRASOUND–FINE NEEDLE ASPIRATION (EUS-FNA) OF LEFT ADRENAL GLAND (LAG) |
122 |
|
P.11.5 THE USE OF A POCKET MOBILE ULTRASOUND DEVICE IN THE EVALUATION OF PATIENTS WITH SUSPECTED BILIARY DISEASE |
122 |
|
P.11.6 ECHOENDOSCOPIC ETHANOL ABLATION OF TUMOR COMBINED TO CELIAC PLEXUS NEUROLYSIS IN PATIENTS WITH PANCREATIC ADENOCARCINOMA |
122 |
|
P.11.7 PANCREATIC FNA: CAN WE GET RID OF THE MICROSCOPE? |
122 |
|
P.11.8 THE ROLE OF EUS-FNA IN THE DIAGNOSIS OF PANCREATIC NEUROENDOCRINE TUMORS |
123 |
|
P.12 Coeliac Disease 2 |
123 |
|
P.12.1 GLUTEN-FREE DIET DOES NOT INFLUENCE THE OCCURRENCE AND THE TH1/TH17-TH2 NATURE OF IMMUNE-MEDIATED DISEASE IN PATIENTS WITH COELIAC DISEASE |
123 |
|
P.12.2 DIAGNOSIS OF CELIAC DISEASE IN ADULTS WITHOUT DUODENAL BIOPSY IN THE PRESENCE OF POSITIVE ANTI-ENDOMYSIUM ANTIBODIES AND ANTI-TRANSGLUTAMINASE ANTIBODIES |
124 |
|
P.12.3 IDENTIFICATION OF A SERUM ANTI-TRANSGLUTAMINASE THRESHOLD VALUE FOR THE NONINVASIVE DIAGNOSIS OF CELIAC DISEASE IN ADULTS |
124 |
|
P.12.4 MACRONUTRIENT INTAKES IN OBESE SUBJECTS WITH OR WITHOUT SMALL INTESTINAL BACTERIAL OVERGROWTH: AN ALIMENTARY SURVEY |
124 |
|
P.12.5 EXOCRINE PANCREATIC INSUFFICIENCY IN ADULT CELIAC DISEASE IS ASSOCIATED WITH SYMPTOM SEVERITY AND READILY RESPONDS TO GLUTEN EXCLUSION |
125 |
|
P.12.6 GENETIC VARIANTS ASSOCIATED WITH ANAEMIA IN ADULT COELIAC PATIENTS: THE ROLE OF TMPRSS6 AND HFE |
125 |
|
P.12.7 OUTCOME OF PATIENTS WITH POSITIVE BREATH TEST FOR SIBO SIX MONTHS AFTER COMBINED TREATMENT WITH RIFAXIMIN AND PROBIOTICS |
125 |
|
P.12.8 INTESTINAL FERMENTATION IN SELF-REPORTED NON-CELIAC GLUTEN SENSITIVITY: A COMPARISON WITH IRRITABLE BOWEL SYNDROME AND HEALTHY VOLUNTEERS |
126 |
|
P.12.9 INTENSIVE COMBINED TREATMENT IN REFRACTORY MORBID OBESITY: OUR EXPERIENCE WITH A GROUP OF PATIENTS NOT ELIGIBLE FOR BARIATRIC SURGERY |
126 |
|
P.12.10 SMALL INTESTINAL BACTERIAL OVERGROWTH IS LINKED TO VASCULAR DISEASE VIA VITAMIN K2-DEPENDENT MECHANISMS |
127 |
|
P.13 Colon 2 |
127 |
|
P.13.1 SPLIT-DOSING REGIMEN FOR BOWEL PREPARATION BEFORE COLONOSCOPY: LOW-VOLUME PEG (POLYETHYLENE GLYCOL) SOLUTIONS VERSUS LARGE-VOLUME PEG SOLUTION IN CLINICAL PRACTICE |
127 |
|
P.13.2 DO WE REALLY NEED BIOPSY TO DIAGNOSE COLORECTAL CANCER? |
128 |
|
P.13.3 EFFICACY OF OSTEOPATHIC MANIPULATIVE TREATMENT ON FUNCTIONAL CONSTIPATION: PILOT STUDY OUTCOME RESEARCH |
128 |
|
P.13.4 A LOW FODMAP DIET IN IRRITABLE BOWEL SYNDROME IMPROVES SYMPTOMS WITHOUT AFFECTING BODY COMPOSITION AND EXTRACELLULAR BODY WATER |
128 |
|
P.13.5 COLONIC FLAT LESIONS DETECTION USING 64-MDCT COLONOGRAPHY, AND A COMPUTER AIDED DETECTION (CAD) SYSTEM. RADIOLOGICAL-ENDOSCOPICAL CORRELATION |
129 |
|
P.13.6 A PRIMARY CARE INTERVENTION MODEL ON THE DIVERTICULAR DISEASE |
130 |
|
P.13.7 CORRELATION BETWEEN GUT PATHOGENS AND FAECAL LACTOFERRIN LEVELS IN CHILDREN WITH ACUTE DIARRHEA |
130 |
|
P.13.9 A PREDICTIVE ROLE OF ANORECTAL MANOMETRIC DIAGNOSIS OF CHRONIC REFRACTORY CONSTIPATION |
131 |
|
P.13.10 NON-ELECTIVE SURGERY FOR ACUTE COMPLICATED DIVERTICULITIS. PRIMARY RESECTION-ANASTOMOSIS OR HARTMANN’S PROCEDURE? A SYSTEMATIC REVIEW AND METAANALYSIS |
131 |
|
P.13.11 KAPLAN-MEIER CUMULATIVE SURVIVAL CURVES: A SIX YEAR EXPERIENCE OF A LARGE VOLUME COLONOSCOPY COLORECTAL CANCER SCREENING CENTER |
131 |
|
P.13.12 OMEGA-3 SUPPLEMENTS FOR RECTAL PATIENTS IN NEOADJUVANT CHEMORADIOTHERAPY |
132 |
|
P.13.13 DYNAMIC TRANSPERINEAL ULTRASOUND FOR THE EVALUATION OF PELVIC FLOOR DISORDERS: WHICH IS THE BEST POSITION? |
132 |
|
P.14 IBD 2 |
133 |
|
P.14.1 EVALUATION OF BONE METABOLISM DURING ANTI-TNF THERAPY IN INFLAMMATORY BOWEL DISEASES |
133 |
|
P.14.2 IS TOPICAL THERAPY UNDERUSED IN PATIENTS WITH ULCERATIVE COLITIS? OUR EXPERIENCE |
133 |
|
P.14.3 CORRELATION BETWEEN CLINICAL RESPONSE AND ANEMIA RESOLUTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES TREATED WITH ANTI-TNF INHIBITORS |
134 |
|
P.14.4 ESCHERICHIA COLI NISSLE 1917 IN ULCERATIVE COLITIS TREATMENT: SYSTEMATIC REVIEW AND META-ANALYSIS |
134 |
|
P.14.5 METASTATIC CUTANEOUS CROHN’S DISEASE OF THE FACE TREATED WITH INFLIXIMAB: CASE REPORT AND FOLLOW UP |
134 |
|
P.14.6 PREVALENCE AND CLINICAL SIGNIFICANCE OF HYPERGAMMAGLOBULINEMIA IN INFLAMMATORY BOWEL DISEASE PATIENTS: A RETROSPECTIVE CROSS-SECTIONAL STUDY |
135 |
|
P.14.7 DRUG ADHERENCE IN IBD PATIENTS |
135 |
|
P.14.8 DO ULCERATIVE COLITIS PATIENTS TREATED WITH CORTICOSTEROIDS AT DIAGNOSIS REALLY HAVE A MORE AGGRESSIVE DISEASE COURSE? |
136 |
|
P.14.9 JEJUNAL CROHN’S DISEASE: CHARACTERISTICS, OUTCOME, NEED OF SURGERY AND IMMUNOMODULATORS IN A RETROSPECTIVE SINGLE-CENTER STUDY |
136 |
|
P.14.10 QUANTIFICATION OF FODMAPS INTAKE IN PATIENTS WITH QUIESCENT INFLAMMATORY BOWEL DISEASE |
137 |
|
P.14.11 METABOLIC SYNDROME: AN UNRECOGNIZED RISK FACTOR IN IBD |
137 |
|
P.14.12 ADHERENCE TO OUTPATIENT FOLLOW-UP VISIT IN IBD PATIENTS |
137 |
|
P.14.13 ENDOSCOPIC ACTIVITY EVALUATION IN ULCERATIVE COLITIS: STILL AN UNSOLVED ISSUE |
138 |
|
P.14.14 EXPLORING THE EPIDEMIOLOGICAL ASPECTS OF IBD: PRELIMINARY DATA FROM EPIMICI STUDY IN SAN MARINO |
138 |
|
P.14.15 EFFICACY AND SAFETY OF INFLIXIMAB AND ADALIMUMAB IN CROHN’S DISEASE PATIENTS IN A SINGLE IBD CENTER: A RETROSPECTIVE REAL-LIFE STUDY |
138 |
|
P.14.16 A NEW THERAPEUTIC LASER SYSTEM FOR ENDOSCOPIC ABLATION OF ESOPHAGEAL LESIONS – FIRST RESULTS IN AN ESTABLISHED ANIMAL MODEL |
139 |
|
P.15 Endoscopy 1 |
139 |
|
P.15.1 ENDOSCOPIC RESECTION OF DUODENAL NEUROENDOCRINE TUMORS: A CASE SERIES OF A SINGLE INSTITUTION |
139 |
|
P.15.2 NEO-ENDOSCOPIC CUL DE SAC OTSC MADE IN DELAYED SURGICAL COMPLICATION |
140 |
|
P.15.3 INCREASED PERFORMANCE OF AN UPDATED ROCKALL SCORE IN ACUTE NON VARICEAL UPPER GASTRO INTESTINAL BLEEDING: A PROSPECTIVE MULTICENTRE ITALIAN STUDY |
140 |
|
P.15.4 BLACK ESOPHAGUS: AN UNCOMMON CAUSE OF NON VARICEAL UPPER GI BLEEDING |
141 |
|
P.15.5 GUIDE WIRE ASSISTED CANNULATION OF MINOR PAPILLA IN PANCREAS DIVISUM: OUR EXPERIENCE |
141 |
|
P.15.7 GUIDELINES ON THE MANAGEMENT OF ANTITHROMBOTIC THERAPY (ATT) FOR ENDOSCOPIC PROCEDURES AND CLINICAL PRACTICE: PRELIMINARY REPORT |
142 |
|
P.15.8 POOR OUTCOME FROM ACUTE UPPER GASTROINTESTINAL BLEEDING IN PATIENTS WITH LIVER CIRRHOSIS: A PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY |
142 |
|
P.15.9 TRANSFUSION STRATEGY AND DEATH RISK IN PATIENTS WITH ACUTE NON VARICEAL UPPER GASTRO INTESTINAL BLEEDING (NV-UGIB) IN ITALY: A PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY |
143 |
|
P.15.10 ENDOSCOPIC TREATMENT OF ANASTOMOTIC STENOSIS AFTER INTESTINAL RESECTION FOR DEEP ENDOMETRIOSIS: A SINGLE CENTER’S EXPERIENCE |
143 |
|
P.15.11 HIGH DOSE VERSUS NON HIGH DOSE OF PROTON PUMP INHIBITORS IN PATIENTS WITH PEPTIC ULCER BLEEDING AFTER ENDOSCOPIC TREATMENT: A META-ANALYSIS |
144 |
|
P.16 Endoscopy 2 |
144 |
|
P.16.1 FIRST NATIONAL REGISTRY ON A NEW DISPOSABLE CHOLANGIOSCOPE FOR SINGLE OPERATOR CHOLANGIOSCOPY |
144 |
|
P.16.2 SMALL BOWEL CAPSULE ENDOSCOPY IN PATIENTS WITH LYNCH SYNDROME. A CASE REPORT |
145 |
|
P.16.3 IMPROVEMENT OF APPROPRIATENESS AND REDUCTION OF WAITING LISTS CONCERNING UPPER GI ENDOSCOPY OUTPATIENTS: A SINGLE-CENTRE PROSPECTIVE STUDY |
145 |
|
P.16.4 ENDOSCOPIC ULTRASOUND-GUIDED TRANSMURAL STENTING FOR GALLBLADDER DRAINAGE IN HIGH RISK PATIENTS WITH ACUTE CHOLECYSTITIS: A SYSTEMATIC REVIEW AND POOLED ANALYSIS |
146 |
|
P.16.5 TRANSORAL OUTLET REDUCTION FOR THERAPY OF WEIGHT REGAIN AFTER GASTRIC BYPASS |
146 |
|
P.16.6 ENDOSCOPIC TREATMENT WITH SELF EXPANDABLE METAL STENT OF NEOPLASTIC COLONIC STRICTURES |
146 |
|
P.16.7 WIRELESS CAPSULE ENDOSCOPY FOR THE DIAGNOSIS OF OBSCURE GASTROINTESTINAL BLEEDING IN VON WILLEBRAND DISEASE: A RETROSPECTIVE CASE SERIES |
147 |
|
P.16.8 UTILIZATION OF OBSERVATION UNIT IN EMERGENCY DEPARTMENT FOR THE FINDING OF OBSCURE GASTROINTESTINAL BLEEDING THROUGH CAPSULE ENDOSCOPY: A PILOT STUDY |
147 |
|
P.16.9 DOES URGENT COLONOSCOPY FOR LOWER GASTROINTESTINAL BLEEDING NEED ORAL BOWEL PREPARATION? |
148 |
|
P.16.10 DOUBLE BALLOON ENTEROSCOPY IN DETECTING SMALL BOWEL NEUROENDOCRINE NEOPLASMS (SB-NENS) |
148 |
|
P.16.11 SIMULTANEOUS ONE-PIECE ENDOSCOPIC SUBMUCOSAL DISSECTION FOR TWO POORLY DIFFERENTIATED EARLY GASTRIC CANCER IN ELDERLY PATIENT |
148 |
|
P.16.12 CAP-ASSISTED MUCOSECTOMY OF COLORECTAL LESIONS: EXPERIENCE OF 59 CASES BY THE GASTROENTEROLOGY AND ENDOSCOPY UNIT – TRENTO |
149 |
|
P.16.13 THE INCIDENCE OF POST-ERCP PANCREATITIS IS NOT REDUCED IN PATIENTS GIVEN INTRAVENOUS KETOROLAC FOR POSTPROCEDURAL ABDOMINAL PAIN |
149 |
|
P.16.14 BILIARY FULLY COVERED SELF EXPANDABLE METAL STENTS: EXPERIENCE IN A SINGLE CENTER |
149 |
|
P.16.15 FAMILIAL ADENOMATOUS POLYPOSIS SMALL BOWEL SURVEILLANCE: COULD INDICATORS FOR VIDEO-CAPSULE ENDOSCOPY BE ASCERTAINED? |
150 |
|
P.17 Endoscopy 3 |
150 |
|
P.17.1 COMPARISON BETWEEN DIFFERENT BOWEL PREPARATION REGIMENS FOR COLONOSCOPY: A SINGLE-CENTRE OBSERVATIONAL STUDY |
150 |
|
P.17.2 USEFULNESS OF PROPHYLACTIC HEMOCLIPS PLACEMENT IN MINIMIZING DELAYED POST-ENDOSCOPIC MUCOSAL RESECTION BLEEDING IN GASTRIC SUPERFICIAL LESIONS: RETROSPECTIVE STUDY |
150 |
|
P.17.3 COLONOSCOPY IN ELDERLY MORE THAN 80 YEARS OLD: OUR EXPERIENCE |
151 |
|
P.17.4 PEG IN VERY ELDERLY PATIENTS WITH DEMENTIA: A SAFE PROCEDURE |
151 |
|
P.17.5 FIBRIN SEALANT (EVICEL®): ENDOSCOPIC INTERVENTIONAL MANAGEMENT OF BLEEDING GASTROINTESTINAL LESIONS: PROSPECTIVE, SINGLE-ARM, PILOT STUDY |
152 |
|
P.17.6 QUALITY OF LIFE AFTER GASTRIC BANDING AND GASTRIC BYPASS FOR MORBID OBESITY: A PROSPECTIVE COMPARISON |
152 |
|
P.17.7 DIGESTIVE BLEEDING IN PEDIATRIC AGE: A SINGLE CENTER EXPERIENCE |
153 |
|
P.17.8 ENDOSCOPIC SUBMUCOSAL DISSECTION LEARNING CURVE: EXPERIENCE OF A LARGE VOLUME COLONOSCOPY CRC ITALIAN SCREENING CENTER |
153 |
|
P.17.9 VIDEOCAPSULAR ENDOSCOPY IN OCCULT OBSCURE GASTROINTESTINAL BLEEDING: REPORT OF FIVE YEARS EXPERIENCE OF A REFERRAL TERTIARY CENTRE |
154 |
|
P.18 Endoscopy 4 |
154 |
|
P.18.1 SMALL BOWEL TUMORS IN PATIENTS UNDERGOING CAPSULE ENDOSCOPY: A SINGLE CENTER EXPERIENCE |
154 |
|
P.18.3 EARLY WAKE UP, ONE DAY LOW FIBER DIET: SPLIT BOWEL EVEN FOR PATIENTS UNDERGOING COLONOSCOPY EARLY IN THE MORNING. A REAL LIFE EXPERIENCE |
155 |
|
P.18.4 CLINICAL OUTCOMES OF PERCUTANEOUS ENDOSCOPIC GASTROSTOMY IN ELDERLY PATIENTS WITH DEMENTIA |
156 |
|
P.18.5 CLINICAL MANAGEMENT AND LONG TERM FOLLOW UP OF PATIENTS WITH OBSCURE GASTROINTESTINAL BLEEDING AND UNCERTAIN SUBMUCOSAL MASSES AT SMALL BOWEL CAPSULE ENDOSCOPY |
156 |
|
P.18.6 ERCP OUTCOMES IN PRESENCE OF A PERIAMPULLARY DIVERTICULUM |
156 |
|
P.18.7 ENDOSCOPIC PAPILLARY LARGE BALLOON DILATION FOR THE REMOVAL OF LARGE STONES IN ELDERLY PATIENTS (80 YEARS OLD OR OVER) |
157 |
|
P.18.8 FAMILIAL ADENOMATOUS POLYPOSIS AND EXTRAINTESTINAL MANIFESTATIONS WITH MALIGNANT POTENTIAL: DIAGNOSTIC AND THERAPEUTIC APPROACH |
157 |
|
P.18.9 ENDOSCOPIC PIECEMEAL RESECTION OF SESSILE OR FLAT COLONIC LESIONS > 2 CM: LONG-TERM RESULTS |
158 |
|
P.18.10 SAFETY AND EFFICACY OF UNDILUITED N-BUTYL-2 CYANOACRYLATE INJECTION AS ENDOSCOPIC RESCUE THERAPY FOR REFRACTORY ACUTE NONVARICEAL UPPER GASTROINTESTINAL BLEEDING |
158 |
|
P.18.11 USE OF PILLCAM COLON 2 IN PATIENTS AT ELEVATED RISK OF COLONOSCOPY ASSOCIATED ADVERSE EVENTS |
159 |
|
P.18.12 HEMOSPRAY IN TREATMENT OF ACUTE BLEEDING DUE TO UPPER GASTROINTESTINAL TUMORS: PRELIMINARY RESULTS |
159 |
|
P.18.13 HEMOSPRAY AS FIRST-LINE AND RESCUE THERAPY FOR GASTROINTESTINAL BLEEDING |
159 |
|
Author Index |
161 |